OPTIMAL ADMINISTRATION DURATION OF URACIL-TEGAFUR ON ADJUVANT CHEMOTHERAPY FOR COMPLETELY RESECTED STAGE I LUNG ADENOCARCINOMA: RETROSPECTIVE ANALYSIS FROM JLCRG PHASE III STUDY

被引：0
|
作者：
Tsuboi, M. [1 ]
Hamada, C. [2 ]
机构：
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan
[2] Tokyo Univ Sci, Fac Engn, Tokyo 162, Japan
[3] Japan Lung Canc Res Grp, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [1] Optimal Administration Duration of Uracil-Tegafur on Adjuvant Chemotherapy for Completely Resected Stage I Lung Adenocarcinoma Retrospective Analysis from JLCRG Phase III Study
    Tsuboi, Masahiro
    Hamada, Chikuma
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S387 - S387
  • [2] The effect of age on adjuvant chemotherapy with uracil-tegafur for completely resected stage I lung adenocarcinoma
    Tsuboi, M.
    Kato, H.
    Ichinose, Y.
    Tada, H.
    Hamada, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer
    Hisashige, A.
    Yoshida, S.
    Kodaira, S.
    BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1232 - 1238
  • [4] Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101)
    Masafumi Yamaguchi
    Hirohito Tada
    Tetsuya Mitsudomi
    Takashi Seto
    Kohei Yokoi
    Nobuyuki Katakami
    Kazuhiko Nakagawa
    Makoto Oda
    Mitsunori Ohta
    Toshiyuki Sawa
    Motohiro Yamashita
    Norihiko Iked
    Hideo Saka
    Masahiko Higashiyama
    Hiroaki Nomori
    Hiroshi Semba
    Shunichi Negoro
    Yasutaka Chiba
    Mototsugu Shimokawa
    Masahiro Fukuoka
    Yoichi Nakanishi
    International Journal of Clinical Oncology, 2021, 26 : 2216 - 2223
  • [5] Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB-IIIA non-small cell lung cancer (WJTOG0101)
    Yamaguchi, Masafumi
    Tada, Hirohito
    Mitsudomi, Tetsuya
    Seto, Takashi
    Yokoi, Kohei
    Katakami, Nobuyuki
    Nakagawa, Kazuhiko
    Oda, Makoto
    Ohta, Mitsunori
    Sawa, Toshiyuki
    Yamashita, Motohiro
    Iked, Norihiko
    Saka, Hideo
    Higashiyama, Masahiko
    Nomori, Hiroaki
    Semba, Hiroshi
    Negoro, Shunichi
    Chiba, Yasutaka
    Shimokawa, Mototsugu
    Fukuoka, Masahiro
    Nakanishi, Yoichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (12) : 2216 - 2223
  • [6] Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer
    Imaizumi, M
    LUNG CANCER, 2005, 49 (01) : 85 - 94
  • [7] A multi-center phase III study of carboplatin/paclitaxel versus oral uracil-tegafur as the adjuvant chemotherapy in resected non-small cell lung cancer
    Toyooka, Shinichi
    Okumura, Norihito
    Nakamura, Hiroshige
    Nakata, Masao
    Yamashita, Motohiro
    Tada, Hirohito
    Kajiwara, Shinsuke
    Watanabe, Naoki
    Okada, Morihito
    Matsuo, Keitaro
    Aoe, Motoi
    Hotta, Katsuyuki
    Sakamoto, Junichi
    Miyoshi, Shinichiro
    Date, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] A multicenter, phase III study of carboplatin/paclitaxel versus oral uracil-tegafur as the adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): Planned interim analyses
    Toyooka, S.
    Hotta, K.
    Nakamura, H.
    Nakata, M.
    Tada, H.
    Yamashita, M.
    Watanabe, N.
    Sakamoto, J.
    Aoe, M.
    Date, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Uracil-tegafur vs fluorouracil as postoperative adjuvant chemotherapy in Stage II and III colon cancer A nationwide cohort study and meta-analysis
    Chen, Po-Huang
    Wu, Yi-Ying
    Lee, Cho-Hao
    Chung, Chi-Hsiang
    Chen, Yu-Guang
    Huang, Tzu-Chuan
    Yeh, Ren-Hua
    Chang, Ping-Ying
    Dai, Ming-Shen
    Lai, Shiue-Wei
    Ho, Ching-Liang
    Chen, Jia-Hong
    Chen, Yeu-Chin
    Hu, Je-Ming
    Yang, Sung-Sen
    Chien, Wu-Chien
    MEDICINE, 2021, 100 (18) : E25756
  • [10] Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients
    Liang, Sheng-Kai
    Wu, Chang-Wei
    Chang, Ching-, I
    Keng, Li-Ta
    Lee, Meng-Rui
    Wang, Jann-Yuan
    Ko, Jen-Chung
    Liao, Wei-Yu
    Chen, Kuan-Yu
    Ho, Chao-Chi
    Shih, Jin-Yuan
    Yu, Chong-Jen
    CANCER MEDICINE, 2023, 12 (17): : 17993 - 18004
12345